Chi Kei Wong
Directeur/Membre du Conseil chez JACOBSON PHARMA CORPORATION LIMITED
Postes actifs de Chi Kei Wong
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JACOBSON PHARMA CORPORATION LIMITED | Directeur/Membre du Conseil | 01/12/2017 | - |
| Independent Dir/Board Member | 01/12/2017 | 14/01/2022 | |
| University of Hong Kong | Corporate Officer/Principal | - | - |
Historique de carrière de Chi Kei Wong
Anciens postes connus de Chi Kei Wong
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Pharmacy & Poisons Board of Hong Kong | Corporate Officer/Principal | 01/01/2019 | 01/01/2021 |
| UCL School of Pharmacy | Corporate Officer/Principal | 01/01/2002 | 01/01/2018 |
| Pharmacy & Poisons Board of Hong Kong | Corporate Officer/Principal | 01/01/2012 | 01/01/2015 |
| UCL Institute of Child Health | Corporate Officer/Principal | 01/01/2002 | 01/01/2011 |
Great Ormond Street Hospital Children's Charity
 Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2002 | 01/01/2011 |
| University of London | Corporate Officer/Principal | 01/01/2002 | 01/01/2011 |
Therakind Ltd.
 Therakind Ltd. Pharmaceuticals: MajorHealth Technology Therakind Ltd. is a British specialty pharmaceutical company that develops niche medicines for difficult-to-treat markets, including paediatric and geriatric patient groups. The private company is based in London, UK. The company's proprietary pipeline focuses on improving medicine adherence through more patient-friendly dosing options. Therakind has a strong track record in the research and development of innovative medicines and drug delivery systems designed specifically for difficult-to-treat patient groups. The company's third product, Jylamvo, has gained regulatory approval. The company was founded in 2006 by Chi Kei Wong, and the CEO is Susan Esther Conroy. | Fondateur | 01/01/2007 | - |
Formation de Chi Kei Wong
| Manchester Medical School | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 7 |
| Hong Kong | 3 |
| Îles Cayman | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 3 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JACOBSON PHARMA CORPORATION LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Pharmacy & Poisons Board of Hong Kong | |
| UCL Institute of Child Health | |
Great Ormond Street Hospital Children's Charity
Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Miscellaneous |
Therakind Ltd.
Therakind Ltd. Pharmaceuticals: MajorHealth Technology Therakind Ltd. is a British specialty pharmaceutical company that develops niche medicines for difficult-to-treat markets, including paediatric and geriatric patient groups. The private company is based in London, UK. The company's proprietary pipeline focuses on improving medicine adherence through more patient-friendly dosing options. Therakind has a strong track record in the research and development of innovative medicines and drug delivery systems designed specifically for difficult-to-treat patient groups. The company's third product, Jylamvo, has gained regulatory approval. The company was founded in 2006 by Chi Kei Wong, and the CEO is Susan Esther Conroy. | Health Technology |
- Bourse
- Insiders
- Chi Kei Wong
- Expérience
